Volume 1, Issue 1 (1-2023)
Neuroscience Updates 2023, 1(1): 9-14 |
Back to browse issues page
1- Faculty of Medicine, Sriwijaya University, Palembang, Indonesia
2- Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
2- Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
Abstract: (5565 Views)
Alzheimer's disease (AD) is a major cause of disability and death. Nowadays, it does not only affect the older population, but also occurs at a very early age (<50 years). Recently, there has been a case finding of the youngest probable AD patient, at the age of 19 years. This calls for a prompt intervention in order to prevent the development of early onset AD in the wider population. Public health measures, accompanied by research projects on the basic, translational, and clinical aspects of the disease, are of crucial importance and must be undertaken and implemented within the global community.
Type of Study: Editorial Commentary |
Subject:
Basic Neuroscience
Received: 2023/07/20 | Accepted: 2023/09/15 | Published: 2023/09/30
Received: 2023/07/20 | Accepted: 2023/09/15 | Published: 2023/09/30
References
1. GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Heal 2022;7:e105-25. [DOI:10.1016/S2468-2667(21)00249-8.] [PMID] [PMCID]
2. Alzheimer's Association. 2020 Alzheimer's disease facts and figures. Alzheimer's Dement 2020;16:391-460. [DOI:10.1002/alz.12068.] [PMID]
3. Zhang X-X, Tian Y, Wang Z-T, Ma Y-H, Tan L, Yu J-T. The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention. J Prev Alzheimer's Dis 2021;8:313-21. [DOI:10.14283/jpad.2021.15] [PMID] [PMCID]
4. Hendriks S, Peetoom K, Bakker C, van der Flier WM, Papma JM, Koopmans R, et al. Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis. JAMA Neurol 2021;78:1080-90. [DOI:10.1001/jamaneurol.2021.2161.] [PMID]
5. Stephan BCM, Pakpahan E, Siervo M, Licher S, Muniz-Terrera G, Mohan D, et al. Prediction of dementia risk in low-income and middle-income countries (the 10/66 Study): an independent external validation of existing models. Lancet Glob Heal 2020;8:e524-35. [DOI:10.1016/S2214-109X(20)30062-0.] [PMID] [PMCID]
6. Stanley K, Walker Z. Do patients with young onset Alzheimer's disease deteriorate faster than those with late onset Alzheimer's disease? A review of the literature. Int Psychogeriatrics 2014;26:1945-53. [DOI:10.1017/S1041610214001173.] [PMID]
7. Blue Cross Blue Shield Association. Early-Onset Dementia and Alzheimer's Rates Grow for Younger American Adults 2020. (accessed August 12, 2023). [Link]
8. Sinyor B, Isaacson R, Ochner C. Preventative medicine and Alzheimer's disease: is Alzheimer's disease risk reduction achievable? Neural Regen Res 2021;16:1772-3. [DOI:10.4103/1673-5374.306086.] [PMID] [PMCID]
9. Pettigrew C, Soldan A. Defining Cognitive Reserve and Implications for Cognitive Aging. Curr Neurol Neurosci Rep 2019;19:1. [DOI:10.1007/s11910-019-0917-z.] [PMID] [PMCID]
10. Schmidt C, Wolff M, Weitz M, Bartlau T, Korth C, Zerr I. Rapidly Progressive Alzheimer Disease. Arch Neurol 2011;68:1124-30. [DOI:10.1001/archneurol.2011.189.] [PMID] [PMCID]
11. Chen K-L, Li P-X, Sun Y-M, Chen S-F, Zuo C-T, Wang J, et al. Very Early-Onset Alzheimer's Disease in the Third Decade of Life with de novo PSEN1 Mutations. J Alzheimer's Dis 2022;85:65-71. [DOI:10.3233/JAD-215167] [PMID]
12. Sirkis DW, Bonham LW, Johnson TP, La Joie R, Yokoyama JS. Dissecting the clinical heterogeneity of early-onset Alzheimer's disease. Mol Psychiatry 2022;27:2674-88. [DOI:10.1038/s41380-022-01531-9] [PMID] [PMCID]
13. Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C. Early-Onset Alzheimer's Disease: What Is Missing in Research? Curr Neurol Neurosci Rep 2021;21:4. [DOI:10.1007/s11910-020-01090-y.] [PMID] [PMCID]
14. Reitz C, Rogaeva E, Beecham GW. Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference? Neurol Genet 2020;6:e512. [DOI:10.1212/NXG.0000000000000512] [PMID] [PMCID]
15. Jia J, Zhang Y, Shi Y, Yin X, Wang S, Li Y, et al. A 19-Year-Old Adolescent with Probable Alzheimer's Disease. J Alzheimers Dis 2023;91:915-22. [DOI:10.3233/JAD-221065.] [PMID]
16. Scheltens P, Rockwood K. How golden is the gold standard of neuropathology in dementia? Alzheimers Dement 2011;7:486-9. [DOI:10.1016/j.jalz.2011.04.011.] [PMID]
17. Macklin K. On the Frontlines of the Alzheimer's Crisis: Advocacy Organizations in Delaware and Nationwide Urge Public Health Intervention to Curb Staggering Disease Trends. Delaware J Public Heal 2021;7:20-3. [DOI:10.32481/djph.2021.09.005.] [PMID] [PMCID]
18. Abela MR, Maxwell H, Bindoff A, Alty J, Farrow M, Lawler K. Pushing through the Barriers: Peer Advice to Increase Physical Activity and Reduce Dementia Risk from Participants in a Massive Open Online Alzheimer's Focused Course. J Prev Alzheimer's Dis 2023;10:503-12. [DOI:10.14283/jpad.2023.42] [PMID] [PMCID]
19. Litke R, Garcharna LC, Jiwani S, Neugroschl J. Modifiable Risk Factors in Alzheimer Disease and Related Dementias: A Review. Clin Ther 2021;43:953-65. [DOI:10.1016/j.clinthera.2021.05.006.] [PMID] [PMCID]
20. Heger I, Köhler S, van Boxtel M, de Vugt M, Hajema K, Verhey F, et al. Raising awareness for dementia risk reduction through a public health campaign: a pre-post study. BMJ Open 2020;10:e041211. [DOI:10.1136/bmjopen-2020-041211] [PMID] [PMCID]
21. Olivari BS, Baumgart M, Lock SL, Whiting CG, Taylor CA, Iskander J, et al. CDC Grand Rounds: Promoting Well-Being and Independence in Older Adults. MMWR Morb Mortal Wkly Rep 2018;67:1036-9. [DOI:10.15585/mmwr.mm6737a4.] [PMID] [PMCID]
22. Draper B, Withall A. Young onset dementia. Intern Med J 2016;46:779-86. [DOI:10.1111/imj.13099] [PMID]
23. Elfaki AO, Alotaibi M. The role of M-health applications in the fight against Alzheimer's: current and future directions. MHealth 2018;4:32. [DOI:10.21037/mhealth.2018.07.03.] [PMID] [PMCID]
24. Costanzo MC, Arcidiacono C, Rodolico A, Panebianco M, Aguglia E, Signorelli MS. Diagnostic and interventional implications of telemedicine in Alzheimer's disease and mild cognitive impairment: A literature review. Int J Geriatr Psychiatry 2020;35:12-28. [DOI:10.1002/gps.5219.] [PMID]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |